107 related articles for article (PubMed ID: 19580543)
1. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
McCallum RW; Burgess JR; Greenaway TM
Med J Aust; 2009 Jul; 191(1):47-8; author reply 48. PubMed ID: 19580543
[No Abstract] [Full Text] [Related]
2. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
3. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.
Coleman RL; Stevens RJ; Retnakaran R; Holman RR
Diabetes Care; 2007 May; 30(5):1292-3. PubMed ID: 17290036
[No Abstract] [Full Text] [Related]
4. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
Yew SQ; Chia YC; Theodorakis M
Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
[TBL] [Abstract][Full Text] [Related]
5. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
Davis WA; Knuiman MW; Davis TM
Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
[TBL] [Abstract][Full Text] [Related]
6. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
7. Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD study.
Tandon S; Wackers FJ; Inzucchi SE; Bansal S; Staib LH; Chyun DA; Davey JA; Young LH;
Diab Vasc Dis Res; 2012 Apr; 9(2):124-30. PubMed ID: 22228772
[TBL] [Abstract][Full Text] [Related]
8. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
Simmons RK; Coleman RL; Price HC; Holman RR; Khaw KT; Wareham NJ; Griffin SJ
Diabetes Care; 2009 Apr; 32(4):708-13. PubMed ID: 19114615
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
[TBL] [Abstract][Full Text] [Related]
10. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.
Game FL; Bartlett WA; Bayly GR; Jones AF
Diabetes Obes Metab; 2001 Aug; 3(4):279-86. PubMed ID: 11520308
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study.
Schimke K; Chubb SA; Davis WA; Davis TM
Atherosclerosis; 2010 Sep; 212(1):321-6. PubMed ID: 20839379
[TBL] [Abstract][Full Text] [Related]
14. Re: Subclinical thyroid dysfunction and mortality in type 2 diabetes.
Badshah I; Chubb SAP; Davis WA; Davis TME
J Diabetes Complications; 2017 Sep; 31(9):1474. PubMed ID: 28645682
[No Abstract] [Full Text] [Related]
15. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
[TBL] [Abstract][Full Text] [Related]
16. Favourable changes in mortality in people with diabetes: US NHANES 1999-2010.
Tsujimoto T; Kajio H; Sugiyama T
Diabetes Obes Metab; 2018 Jan; 20(1):85-93. PubMed ID: 28640432
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
18. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context.
Gore MO; McGuire DK
Diab Vasc Dis Res; 2009 Jan; 6(1):53-5. PubMed ID: 19156632
[No Abstract] [Full Text] [Related]
19. Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
Diab Vasc Dis Res; 2013 Mar; 10(2):143-51. PubMed ID: 22786872
[TBL] [Abstract][Full Text] [Related]
20. Changes in certification of diabetes with cardiovascular diseases increased reported diabetes mortality in Australia and the United States.
Adair T; Rao C
J Clin Epidemiol; 2010 Feb; 63(2):199-204. PubMed ID: 19664902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
